333 related articles for article (PubMed ID: 29799176)
1. Cervical cancer staging, pretreatment planning, and surgical treatment in the Nordic countries-Survey from the Surgical Subcommittee of the Nordic Society of Gynecological Oncology.
Fuglsang K; Haldorsen IS; Avall-Lundqvist E; Lindahl G; Roed H; Woie K; Pakarinen P; Thoroddsen A; Anttila M; Blaakaer J
Acta Obstet Gynecol Scand; 2018 Oct; 97(10):1178-1184. PubMed ID: 29799176
[TBL] [Abstract][Full Text] [Related]
2. Nonepithelial ovarian cancer - the current clinical practice in the Nordic countries. Survey from the surgical subcommittee of the Nordic society of gynecological oncology (NSGO).
Daviu C; Blaakaer J; Eriksson AGZ; Herrstedt J; Vandborg MP; Rasmussen AMO; Fuglsang K
Acta Oncol; 2022 Aug; 61(8):939-945. PubMed ID: 35762031
[TBL] [Abstract][Full Text] [Related]
3. Changing trend in the patterns of pretreatment diagnostic assessment for patients with cervical cancer in Japan.
Tomita N; Toita T; Kodaira T; Shinoda A; Uno T; Numasaki H; Teshima T; Mitsumori M
Gynecol Oncol; 2011 Dec; 123(3):577-80. PubMed ID: 21945554
[TBL] [Abstract][Full Text] [Related]
4. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.
Hricak H; Gatsonis C; Chi DS; Amendola MA; Brandt K; Schwartz LH; Koelliker S; Siegelman ES; Brown JJ; McGhee RB; Iyer R; Vitellas KM; Snyder B; Long HJ; Fiorica JV; Mitchell DG; ;
J Clin Oncol; 2005 Dec; 23(36):9329-37. PubMed ID: 16361632
[TBL] [Abstract][Full Text] [Related]
5. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
Fischerová D; Cibula D
Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment retroperitoneal para-aortic lymph node staging in advanced cervical cancer: a review.
Smits RM; Zusterzeel PL; Bekkers RL
Int J Gynecol Cancer; 2014 Jul; 24(6):973-83. PubMed ID: 24978708
[TBL] [Abstract][Full Text] [Related]
7. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA
Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068
[TBL] [Abstract][Full Text] [Related]
8. Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?
Gucer F; Misirlioglu S; Ceydeli N; Taskiran C
J Robot Surg; 2018 Mar; 12(1):49-58. PubMed ID: 28255734
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.
Morkel M; Ellmann A; Warwick J; Simonds H
Int J Gynecol Cancer; 2018 Feb; 28(2):379-384. PubMed ID: 29324535
[TBL] [Abstract][Full Text] [Related]
10. MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes.
Pandharipande PV; Choy G; del Carmen MG; Gazelle GS; Russell AH; Lee SI
AJR Am J Roentgenol; 2009 Mar; 192(3):802-14. PubMed ID: 19234280
[TBL] [Abstract][Full Text] [Related]
11. Lacunae in International Federation of Gynecology and Obstetrics (FIGO) classification for cervical carcinoma: observational study using TNM classification as comparator.
Meva J; Chaudhary RK; Bhaduri D; Bhatia M; Hatti S; Ba R
Int J Gynecol Cancer; 2013 Jul; 23(6):1071-7. PubMed ID: 23792602
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment staging of cervical cancer: is imaging better than palpation?: Role of CT and MRI in preoperative staging of cervical cancer: single institution results for 255 patients.
Hancke K; Heilmann V; Straka P; Kreienberg R; Kurzeder C
Ann Surg Oncol; 2008 Oct; 15(10):2856-61. PubMed ID: 18696156
[TBL] [Abstract][Full Text] [Related]
13. What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?
Haldorsen IS; Lura N; Blaakær J; Fischerova D; Werner HMJ
Curr Oncol Rep; 2019 Jul; 21(9):77. PubMed ID: 31359169
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study.
Choi HJ; Roh JW; Seo SS; Lee S; Kim JY; Kim SK; Kang KW; Lee JS; Jeong JY; Park SY
Cancer; 2006 Feb; 106(4):914-22. PubMed ID: 16411226
[TBL] [Abstract][Full Text] [Related]
15. The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer.
Papadia A; Gasparri ML; Genoud S; Bernd K; Mueller MD
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2275-2281. PubMed ID: 28669052
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes in patients with cervical cancer after inclusion of PET/CT in staging procedures.
Hansen HV; Loft A; Berthelsen AK; Christensen IJ; Høgdall C; Engelholm SA
Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1833-9. PubMed ID: 26194714
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological guideline influence on the therapeutic trend and patient outcome of uterine cervical cancer in Japan: Japan society of gynecologic oncology guideline evaluation committee project.
Shigeta S; Shida M; Nagase S; Ikeda M; Takahashi F; Shibata T; Yamagami W; Katabuchi H; Yaegashi N; Aoki D; Mikami M
Gynecol Oncol; 2020 Oct; 159(1):248-255. PubMed ID: 32718728
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of preoperative cross-sectional imaging in cervical cancer patients undergoing primary radical surgery.
Staley SA; Tucker KR; Gehrig PA; Clark LH
Gynecol Oncol; 2021 Feb; 160(2):384-388. PubMed ID: 33213900
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
[TBL] [Abstract][Full Text] [Related]
20. Do clinical characteristics and metabolic markers detected on positron emission tomography/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?
Akkas BE; Demirel BB; Dizman A; Vural GU
Ann Nucl Med; 2013 Oct; 27(8):756-63. PubMed ID: 23793926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
